News

Welcome to the news and media section of our website, where we feature corporate news releases and media coverage of interest.

 

Show by Tag

horse's face after 4 Immunocidin treatments

Equine Sarcoid Tumor Product Now Available to U.S. Veterinarians

NovaVive now offers an equine-specific version of its Immunocidin® product for equine sarcoids in response to demand by U.S. veterinarians. Immunocidin® Equine is packaged in 5mL vials for the convenience of practitioners.

learn more
mare with foal in field

Settle®: A Regulator-Approved Antibiotic Alternative for Treating Equine Endometritis

NovaVive offers an alternative to antibiotics for the treatment of equine endometritis: Settle®. This product is fully approved by regulators in the U.S. and Australia for endometritis caused by Streptococcus zooepidemicus.

learn more
close-up of horse's face

U.S. and Canadian Regulator-Approved Immunotherapeutic Available for Equine Sarcoid Tumors

NovaVive's cancer immunotherapy, Immunocidin(R), received USDA and CFIA approval for the treatment of equine sarcoid tumors in February, 2016. The Company believes that this is North America's first approved sarcoid therapy.

learn more
  • 2 / 2

Sign up to stay up-to-date with NovaVive news.